His main research concerns Pathology, Internal medicine, Radiology, Lung and Idiopathic pulmonary fibrosis. His Pathology study combines topics from a wide range of disciplines, such as Respiratory disease, Limbic encephalitis, Anti-NMDA receptor encephalitis and Interstitial lung disease. His Limbic encephalitis research integrates issues from Autoimmune encephalitis and Ovarian Teratoma.
His study in Anti-NMDA receptor encephalitis is interdisciplinary in nature, drawing from both Teratoma and Potassium channel complex. His Internal medicine study combines topics in areas such as Endocrinology, Surgery, Physical therapy and Cardiology. His Idiopathic pulmonary fibrosis research incorporates elements of Pulmonary fibrosis, Medical diagnosis and Intensive care medicine.
His primary scientific interests are in Internal medicine, Ataxia, Radiology, Pathology and Lung. David A. Lynch works mostly in the field of Internal medicine, limiting it down to concerns involving Cardiology and, occasionally, Airway. His Ataxia research includes themes of Genetics, Disease, Degenerative disease, Frataxin and Pediatrics.
His studies deal with areas such as Idiopathic pulmonary fibrosis and Usual interstitial pneumonia as well as Radiology. He has researched Usual interstitial pneumonia in several fields, including Idiopathic interstitial pneumonia, Honeycombing and Lung biopsy. The concepts of his Pathology study are interwoven with issues in Respiratory disease and Interstitial lung disease.
David A. Lynch mostly deals with Internal medicine, Ataxia, COPD, Lung and Radiology. His Internal medicine study incorporates themes from Gastroenterology, Oncology and Cardiology. His Ataxia research is multidisciplinary, incorporating perspectives in Clinical trial, Disease, Frataxin, Biomarker and Mitochondrion.
David A. Lynch has included themes like Pulmonary disease, Spirometry, Lung function and Cohort in his COPD study. David A. Lynch has researched Lung in several fields, including Abnormality and Pathology. David A. Lynch interconnects Proportional hazards model, Idiopathic pulmonary fibrosis, Bronchiectasis and Interstitial lung disease in the investigation of issues within Pulmonary fibrosis.
David A. Lynch mainly investigates Internal medicine, COPD, Ataxia, Lung and Interstitial lung disease. His Internal medicine research incorporates themes from Gastroenterology, Oncology and Cardiology. His COPD research incorporates elements of Genetic epidemiology, Spirometry, Cohort and Hazard ratio.
His study in Ataxia is interdisciplinary in nature, drawing from both Clinical trial, Physical medicine and rehabilitation, Young adult, Placebo and Frataxin. The study incorporates disciplines such as Computed tomography, Position paper, Pathology and Abnormality in addition to Lung. His biological study spans a wide range of topics, including Radiology, Idiopathic pulmonary fibrosis, Chemotherapy and Lung cancer screening.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement
Jr King;U. Costabel;J. F. Cordier;G. A. DoPico.
American Journal of Respiratory and Critical Care Medicine (2000)
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Josep Dalmau;Amy J Gleichman;Ethan G Hughes;Jeffrey E Rossi.
Lancet Neurology (2008)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)
Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma
Josep Dalmau;Erdem Tüzün;Hai-yan Wu;Jaime Masjuan.
Annals of Neurology (2007)
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown.
American Journal of Respiratory and Critical Care Medicine (2007)
Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents
Nicole R. Florance;Rebecca L. Davis;Christopher Lam;Christina Szperka.
Annals of Neurology (2009)
The national lung screening trial: Overview and study design
Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Ethan G. Hughes;Xiaoyu Peng;Amy J. Gleichman;Meizan Lai.
The Journal of Neuroscience (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: